Vicore Pharma Holding AB (publ) (STO: VICO)
Sweden
· Delayed Price · Currency is SEK 7.75
+0.25 (3.33%)
Oct 4, 2024, 5:29 PM CET
Vicore Pharma Holding AB Revenue
Vicore Pharma Holding AB had revenue of 104.24M SEK in the twelve months ending June 30, 2024.
Revenue (ttm)
104.24M
Revenue Growth
n/a
P/S Ratio
8.26
Revenue / Employee
3.72M
Employees
24
Market Cap
865.94M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 520.76B |
| Swedish Orphan Biovitrum AB (publ) | 23.71B |
| Getinge AB (publ) | 33.33B |
| Sectra AB (publ) | 3.17B |
| Camurus AB (publ) | 1.59B |
| Vitrolife AB (publ) | 3.54B |
| Medicover AB (publ) | 21.70B |
| Elekta AB (publ) | 18.12B |